Air Stacking-Assisted Diaphragmatic Breathing in Stroke
Effects of Diaphragmatic Breathing Exercise Using the Air Stacking Technique on Respiratory and Trunk Function in Patients With Stroke: A Randomized Controlled Trial
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this study is to investigate whether a diaphragmatic breathing exercise using the air stacking technique can improve respiratory function and trunk control in patients with stroke. The experimental group will perform an air stacking-based diaphragmatic breathing exercise using an Ambu-bag, combined with neurodevelopmental treatment, three times per week for 20 minutes over a 4-week period. The control group will receive therapist-guided diaphragmatic breathing exercises with the same frequency and duration, together with the same neurodevelopmental treatment. All participants will be assessed before and after the intervention for pulmonary function, chest wall expansion, and trunk control ability, as well as the Korean version of the Trunk Impairment Scale (K-TIS), the Five Times Sit-to-Stand Test (FTSTS), and the Borg Rating of Perceived Exertion (Borg RPE). Changes between the two groups will be compared to determine the therapeutic effectiveness of the air stacking technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Sep 2025
Shorter than P25 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 21, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 21, 2026
CompletedFirst Submitted
Initial submission to the registry
April 28, 2026
CompletedFirst Posted
Study publicly available on registry
May 11, 2026
CompletedMay 11, 2026
May 1, 2026
5 months
April 28, 2026
May 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in Forced Vital Capacity (FVC)
Forced vital capacity (FVC) will be assessed using spirometry at baseline and 4 weeks after the start of the intervention. The outcome measure is the change in FVC from baseline to 4 weeks in each group.
Baseline and 4 weeks after the start of intervention
Change in Forced Expiratory Volume in 1 Second (FEV1)
Forced expiratory volume in 1 second (FEV1) will be assessed using spirometry at baseline and 4 weeks after the start of the intervention. The outcome measure is the change in FEV1 from baseline to 4 weeks in each group.
Baseline and 4 weeks after the start of intervention
Change in FEV1/FVC ratio
The ratio of forced expiratory volume in 1 second to forced vital capacity (FEV1/FVC) will be assessed using spirometry at baseline and 4 weeks after the start of the intervention. The outcome measure is the change in FEV1/FVC from baseline to 4 weeks in each group.
Baseline and 4 weeks after the start of intervention
Change in Peak Expiratory Flow (PEF)
Peak expiratory flow (PEF) will be assessed using spirometry at baseline and 4 weeks after the start of the intervention. The outcome measure is the change in PEF from baseline to 4 weeks in each group.
Baseline and 4 weeks after the start of intervention
Secondary Outcomes (3)
Change in Trunk Function (Korean Version of the Trunk Impairment Scale, K-TIS)
Baseline and 4 weeks after the start of intervention
Change in Functional Lower Extremity Performance (Five Times Sit-to-Stand Test, FTSTS)
Baseline and 4 weeks after the start of intervention
Change in Perceived Exertion (Borg Rating of Perceived Exertion Scale)
Baseline and 4 weeks after the start of intervention
Study Arms (2)
Air stacking-assisted diaphragmatic breathing
EXPERIMENTALarticipants in this arm will receive diaphragmatic breathing exercises using the air stacking technique with an Ambu-bag three times per week for 20 minutes over 4 weeks, in addition to routine neurodevelopmental treatment.
diaphragmatic breathing
ACTIVE COMPARATORParticipants in this arm will receive diaphragmatic breathing exercises three times per week for 20 minutes over 4 weeks, together with the same neurodevelopmental treatment as the experimental group.
Interventions
diaphragmatic breathing exercise performed three times per week for 20 minutes over 4 weeks, together with the same neurodevelopmental treatment as the experimental group.
Diaphragmatic breathing exercise using the air stacking technique with an Ambu-bag, performed three times per week for 20 minutes over 4 weeks, in addition to routine neurodevelopmental treatment.
Eligibility Criteria
You may qualify if:
- Inpatients diagnosed with stroke (intracerebral hemorrhage or cerebral infarction) at a general hospital in Daegu, currently receiving physical therapy
- Onset of stroke at least 3 months prior to enrollment
- Spasticity grade of 2 or less on the Modified Ashworth Scale
- No congenital deformity or fracture of the thorax or other orthopedic conditions affecting the chest wall
- No history of pulmonary disease before or after the stroke
- Able to perform respiratory exercises as instructed
- Mini-Mental State Examination-Korean version (MMSE-K) score of 24 or higher, indicating sufficient cognitive ability to understand the study procedures
- Presence of decreased pulmonary function (reduced pulmonary function test parameters) at baseline
You may not qualify if:
- Acute stroke status or onset of stroke less than 3 months prior to enrollment
- Severe cardiovascular or respiratory disease that makes participation in respiratory exercise unsafe or impossible
- Cognitive impairment or communication disorder that prevents understanding or performing the study procedures
- Any other medical or safety condition judged by the investigator to make participation in the study inappropriate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- jang ji-hunlead
Study Sites (1)
Daegu Fatima Hospital
Daegu, Daegu, 41199, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessments will be performed by a physical therapist who is blinded to group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Physical Therapist, Principal Investigator
Study Record Dates
First Submitted
April 28, 2026
First Posted
May 11, 2026
Study Start
September 25, 2025
Primary Completion
February 21, 2026
Study Completion
February 21, 2026
Last Updated
May 11, 2026
Record last verified: 2026-05